Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial (Q44731158)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial |
scientific article |
Statements
1 reference
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial. (English)
1 reference
1 reference
Robert M Jasmer
1 reference
David C Snyder
1 reference
Jussi J Saukkonen
1 reference
Philip C Hopewell
1 reference
Mark D King
1 reference
L Masae Kawamura
1 reference
Charles L Daley
1 reference
Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection Study Investigators
1 reference
13 January 2004
1 reference
1 reference
Identifiers
1 reference